Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Head and neck mucosal melanoma.

William M Mendenhall1, Robert J Amdur, Russell W Hinerman

  • 1Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA.

American Journal of Clinical Oncology
|December 1, 2005
PubMed
Summary

Optimal treatment for head and neck mucosal melanoma is surgery. While radiotherapy (RT) can improve local control, it may not significantly impact survival rates for this rare cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Radiation Oncology Match in 2025: A New Steady-State?

Practical radiation oncology·2025
Same author

Pattern of recurrence with 1.0 cm CTV in brain glioblastoma treated with radiotherapy.

Journal of neuro-oncology·2025
Same author

PRO's Top 20 Downloads of 2024.

Practical radiation oncology·2025
Same author

Rosai-Dorfman Disease: The Role of Radiation Therapy.

Practical radiation oncology·2025
Same author

Modelling of a double-scattering proton therapy nozzle using the FLUKA Monte Carlo code and analysis of linear energy transfer in patients treated for prostate cancer.

Journal of applied clinical medical physics·2025
Same author

A multi-institutional retrospective cohort of adult-onset medulloblastoma in the modern era.

Neuro-oncology advances·2025

Area of Science:

  • Oncology
  • Head and Neck Surgery
  • Melanoma Research

Background:

  • Head and neck mucosal melanoma is a rare cancer, accounting for less than 1% of all Western melanomas.
  • This malignancy typically originates in the nasal cavity, paranasal sinuses, or oral cavity.

Purpose of the Study:

  • To review and discuss the optimal treatment strategies and outcomes for head and neck mucosal melanoma.
  • To provide insights into the management of this rare oncological entity.

Main Methods:

  • A comprehensive review of the pertinent medical literature was conducted.
  • Key findings regarding treatment efficacy and patient outcomes were synthesized.

Main Results:

  • Surgery is identified as the primary treatment modality for head and neck mucosal melanoma.

Related Experiment Videos

  • Local recurrence rates after surgical resection approach 50%; radiotherapy (RT) can reduce local failure but does not consistently improve survival.
  • Survival rates at 5 years range from 20% to 50%, with late relapses being common and impacting long-term outcomes.

    • Conclusions:

    • Surgical intervention remains the cornerstone of treatment for head and neck mucosal melanoma.
    • Postoperative RT enhances local-regional control but its impact on overall survival is uncertain.
    • Definitive RT may offer curative potential for unresectable cases or provide substantial palliation.